GPhC CRA: question practice and revision.

Choose a topic for focused revision and check your plan against the official specification.

• High-weighted learning outcomes
• Medium-weighted learning outcomes
• Low-weighted learning outcomes

Distilled from GPhC Board of Assessors feedback across multiple sittings and iatroX item density.

• Pharmaceutical calculations (Part 1) — IV infusion rates, paediatric weight-based dosing, displacement values for reconstitution, percentage and ratio concentrations, Cockcroft–Gault dose adjustment
• Clinical therapeutics in common chronic disease — diabetes, cardiovascular disease, respiratory, mental health, infection
• Pharmacy law and governance — controlled drug prescription validity, emergency supply rules, registration and conduct, Patient Group Directions
• Patient safety — anticoagulation monitoring, high-risk medicines, look-alike sound-alike, error reporting
• Renal and hepatic dose adjustment using current product information, approved medicines references and CrCl interpretation
• Counselling points and red-flag triage for self-care presentations in community pharmacy

Direct from GPhC Board of Assessors feedback documents across multiple sittings. These remain consistent year on year — meaning they are predictable and drillable.

GPhC Board of Assessors feedback — synthesised by iatroX.

1. Part 1: Displacement values ignored when reconstituting injectable powders, leading to systematic dosing errors.
2. Part 1: Rounding at the wrong stage of multi-step calculations — round only at the final answer.
3. Part 1: IV infusion rate unit mismatches (microgram vs milligram, mL/hour vs drops/minute).
4. Part 1: Time pressure on later questions — early questions consume disproportionate time and later items go unanswered.
5. Part 2: CD prescription validity — missing the required quantity in words and figures, prescriber address, or date.
6. Part 2: Emergency supply provisions — confusing patient-request rules with prescriber-request rules.
7. Part 2: Prescribing in renal impairment — knowing a dose adjustment is needed but not how to apply the supplied resource or current product-specific information.
8. Part 2: Drug interaction management — recognising the interaction but not the clinical action (adjust dose, monitor, or avoid).

A pragmatic plan used by iatroX-supported first-time passers in 2024–25.

1. Weeks 1–2

   Framework mapping and baseline. Download the 2026 CRA framework. Run a diagnostic across all CRA areas. Identify your bottom three therapeutic areas and your weakest calculation type.

2. Weeks 3–5

   Systematic Part 2 therapeutics — start with the high-weighted areas (chronic disease management, infection, mental health). Review current product-specific information and applicable professional guidance alongside iatroX SBAs.

3. Weeks 6–8

   Daily Part 1 calculation drilling. 20 timed calculations per day. Focus on the four failure points: displacement, rounding, infusion units, time pressure.

4. Weeks 9–11

   Pharmacy law, governance and self-care. MEP cover-to-cover. Two timed mixed Part 1 + Part 2 mock exams under exam conditions.

5. Week 12

   Light review of bookmarked questions only. Confirm Pearson VUE booking, calculator policy and admission requirements.

Dedicated GPhC CRA question practice with answer explanations, guided Tutor review and study planning.

• Focused question practice — Choose the relevant bank and use your answers to identify what to study next.
• Guided reasoning — Explore a difficult answer with Tutor, then apply the distinction independently.
• Review and timed practice — Return to important mistakes and choose a timed practice set where available.

Choose the relevant bank and use the official exam guidance to plan your preparation.

The June 2025 sitting had a 77% overall pass rate (2,247 of 2,913 candidates). The November 2025 sitting had a 62% pass rate (722 of 1,174). November sittings consistently have lower pass rates than June — typically 56–66% versus 75–80%.

You must pass Part 1 AND Part 2 in the same sitting. There is no compensation between parts. The pass mark is set per sitting using a modified Angoff methodology plus one Standard Error of Measurement. In June 2025 the Part 1 pass mark was 24/40 and Part 2 was 79/120.

Part 1 uses free-entry numerical answers — you type your answer exactly as you would in real practice, not select from options. Each question has a clinically acceptable answer range. You have 120 minutes for 40 questions, with a GPhC-approved calculator.

Full GPhC CRA bank access is included in all-access. Up to 10 new sample questions per day are shared across exams, with no account required. A verified free account includes one guided Tutor session; continued Tutor use is included in all-access.

From 2026, independent prescribing content (learning outcome 37) is excluded from the CRA so that all trainees — whether they completed an integrated prescribing course or not — sit the same exam. Format and content areas otherwise remain unchanged through at least 2029.